Patients with non-alcoholic steatohepatitis exhibit elevated palmitoylation of CD36, which aggravates lipid accumulation and immune-cell infiltration in the liver 65, and tumor cells exhibiting metastatic potential express increased levels of CD36 and show elevated FA-uptake activity. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatohepatitis.